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Summary
Spinal muscular atrophy (SMA) is a common fatal mo-
tor-neuron disorder characterized by degeneration of the
anterior horn cells of the spinal cord, which results in
proximal muscle weakness. Three forms of the disease,
exhibiting differing phenotypic severity, map to chro-
mosome 5q13 in a region of unusually high genomic
variability. The SMA-determining gene (SMN) is deleted
or rearranged in patients with SMA of all levels of se-
verity. A high de novo mutation rate has been estimated
for SMA, based on the deletion of multicopy microsat-
ellite markers. We present a type I SMA family in which
a mutant SMA chromosome has undergone a second
mutation event. Both the occurrence of three affected
siblings harboring this same mutation in one generation
of this family and the obligate-carrier status of their
mother indicate the existence of maternal germ-line mo-
saicism for cells carrying the second mutation. The ex-
istence of secondary mutational events and of germ-line
mosaicism has implications for the counseling of SMA
families undergoing prenatal genetic analysis.
Introduction
Childhood-onset proximal spinal muscular atrophy
(SMA) (MIM 253300, 253550, and 253400) is a com-
mon neurodegenerative disorder affecting ∼1 in 10,000
live births per year (Dubowitz 1995). The disease is clas-
sified, on the basis of age at onset and clinical severity,
into three subtypes: type I (severe), type II (intermediate),
and type III (mild) (Munsat and Davies 1992). All three
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forms of SMA map to one locus on chromosome 5q13
(Brzustowicz et al. 1990; Gilliam et al. 1990; Melki et
al. 1990a, 1990b). The SMA-determining gene, the sur-
vival motor-neuron gene (SMN), is present in two almost
identical copies, each of which is contained within a
large inverted duplicated region (Lefebvre et al. 1995).
The telomeric SMN gene (SMNtel) is deleted or rear-
ranged in patients with SMA of all levels of severity
(Bussaglia et al. 1995; Cobben et al. 1995; Hahnen et
al. 1995, 1997; Lefebvre et al. 1995; Rodrigues et al.
1995, 1996; Brahe et al. 1996; Matthijs et al. 1996;
Parsons et al. 1996; Velasco et al. 1996; Simard et al.
1997; Talbot et al. 1997a). Gene conversion was im-
plicated in the disease mechanism when patients in
whom SMNtel exon 7 was deleted but SMNtel exon 8
was retained were found to contain hybrid genes with
SMNcen exon 7 linked to SMNtel exon 8 (Bussaglia et
al. 1995; Cobben et al. 1995; Hahnen et al. 1995, 1996;
Lefebvre et al. 1995; Rodrigues et al. 1995, 1996; De-
vriendt et al. 1996; van der Steege et al. 1996; Velasco
et al. 1996; DiDonato et al. 1997; Simard et al. 1997;
Talbot et al. 1997b). Direct physical evidence for the
role of gene conversion of the entire SMNtel gene, in-
cluding exon 8, in SMA types II and III was obtained
from pulsed-field genomic analysis of the SMA region
(Campbell et al. 1997). The clinical phenotype appears
to be determined by the underlying mutational mecha-
nism. Most cases of severe SMA result from gene-de-
letion events, whereas the milder forms of the disease
result from gene conversion of SMNtel to its centromeric
counterpart, SMNcen. Differences in SMA phenotype
may therefore be accounted for by the number of
SMNcen gene copies present. Patients suffering from the
milder forms of SMA contain more SMNcen copies, as
a result of gene conversion of SMNtel, each of which
produces a small amount of functional full-length SMN
protein (Campbell et al. 1997; Coovert et al. 1997; Le-
febvre et al. 1997). Recent studies involving the iden-
tification of protein-protein interactions by yeast two-
hybrid screening have suggested possible roles for the
SMN protein product both in spliceosomal small nuclear
ribonucleoprotein biogenesis and in the prevention of
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apoptotic cell death via interaction with bcl-2 (Fischer
et al. 1997; Iwahashi et al. 1997; Liu et al. 1997).
Each duplicated region also contains either a func-
tional or a pseudogene copy of the gene encoding the
neuronal apoptosis-inhibitory protein (NAIP) (Roy et al.
1995). Deletions of the functional telomeric NAIP gene
are most often associated with type I SMA (Hahnen et
al. 1995; Roy et al. 1995; Wirth et al. 1995; Burlet et
al. 1996; Rodrigues et al. 1996; Velasco et al. 1996).
A third gene, BTF2p44, encoding a subunit of the
transcription factor TFIIH, exists in each duplicated re-
gion (Humbert et al. 1994; van der Steege et al. 1995a).
A correlation has been shown between deletion of the
telomeric BTF2p44 gene and severe SMA, but the pro-
tein structure and function were found to be normal in
patients homozygously deleted for this gene, which sug-
gests that it is not critical in the development of SMA
(Burglen et al. 1997).
The genomic region containing the gene mutated in
SMA is highly variable in size among unrelated individ-
uals, even in a highly homogeneous population from
northern Finland (Campbell et al. 1997). Chromosome
5–specific repeat sequences are known to exist in the
region. Pseudogene sequences of the b-glucuronidase
and Br-cadherin genes have been shown to account for
some of these and, by mediation of recombination
events, may contribute to instability (Sargent et al. 1994;
Theodosiou et al. 1994; Selig et al. 1995). In addition,
sequences homologous to the human retrotransposable
element, THE1, may be implicated in the generation of
instability in the SMA region (Francis et al. 1995). THE1
elements are also known to occur in the dystrophin gene,
in regions with a particularly high frequency of deletion
(Pizzuti et al. 1992; McNaughton et al. 1993).
The inherent instability of the SMA region is further
demonstrated by the occurrence of de novo deletions
involving the multicopy microsatellite markers C272 (or
Ag1CA) and C212, which are associated with each SMN
gene copy (Melki et al. 1994; Capon et al. 1995; Daniels
et al. 1995). The identification of a de novo deletion
involving both of these markers in the more severely
affected of two haploidentical siblings, both of whom
showed SMNtel deletion, highlights the unstable nature
of this region (Parano et al. 1996). The identification of
seven de novo mutations involving loss of these markers
in a study of 340 families has led to an estimation of
the mutation rate for SMA as , suggesting a41.1# 10
high rate of mutation in this region (Wirth et al. 1997).
The same study determined that, in six cases, the mu-
tation was paternal in origin, implicating rearrangement
during paternal meiosis as the major mutational
mechanism.
Here we present an unusual family in which type I
SMA appears to result from a secondary mutational
event on a chromosome already carrying an SMA mu-
tation. This result suggests that, in addition to a high de
novo mutation rate, some SMA mutant chromosomes
may harbor a propensity to undergo further mutation.
Both the occurrence of the disease in three haploidentical
siblings and the pulsed field–gel electrophoresis (PFGE)
analysis of this family indicate the existence of maternal
germ-line mosaicism for this mutation. The analysis of
such a family by PFGE presents a unique opportunity
to follow the progress of such a mutational event and
to determine its origin. The occurrence of germ-line mo-
saicism has implications for genetic counseling.
Subjects, Material, and Methods
Subjects
All patients conformed to internationally agreed di-
agnostic criteria (Munsat and Davies 1992). Informed
consent was obtained from all subjects. DNA for hap-
lotype analysis was prepared from blood taken into Na-
EDTA by the Nucleon II method (Anachem).
PCR Analysis
Genotyping of DNA from family memberswas carried
out by standard PCR analysis incorporating radiola-
beled a-[35S] d-ATP, as described elsewhere (Daniels et
al. 1992; Morrison et al. 1992). Genotypes were ob-
tained at the following loci: D5S679, D5S125, D5S681,
D5S435, D5S557, D5S610, D5S112, and D5S39CA.
Analysis with CATT-alt (a sublocus of the multicopy
marker C161) primers was carried out as described by
Daniels et al. (1995).
PFGE
High–molecular-weight genomic DNA was prepared
from cultured lymphocytes embedded in low–gelling-
temperature agarose and was subjected to PFGE, as de-
scribed elsewhere (Campbell et al. 1997).
Results
Family Genotypes in the SMA Region
Genotyping of the family whose pedigree is shown in
figure 1 was carried out with microsatellite markers
flanking the SMA locus on chromosome 5q13. Genotype
results are shown diagrammatically as individual chro-
mosomes inherited by each member of the family. The
three affected siblings, III1, III2, and III3, were haplo-
identical at all loci analyzed. The carrier status of un-
affected siblings was determined by this haplotype anal-
ysis. Genotyping of this family with primers flanking
CATT-alt revealed the passage of null alleles from both
grandparental carrier individuals to each carrier parent
(fig. 2) (Melki et al. 1994; Daniels et al. 1995). Null
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Figure 1 Genotype analysis of three generations of a type I SMA
family. PCR amplification involving incorporation of a-[35S] d-ATP
was carried out by means of primers flanking microsatellite repeats
surrounding the SMA locus on chromosome 5q13. Markers used are
as shown (left). The position of the SMA locus relative to the two
closest flanking markers used is shown by an arrowhead. Black bars
represent the maternal and grandmaternal mutant chromosome 5. The
paternal mutant chromosome 5 is shaded gray. Individual II3 has in-
herited a recombination event that occurred proximal to the SMA
locus and that does not affect her inheritance of the mutant SMA gene.
DNA from individuals II4 and III6 was unavailable for analysis. All
three affected siblings, III1, III2, and III3, were haploidentical at all loci
tested. Individuals in generation III are not depicted according to con-
vention, with the eldest on the left, but instead are shown in the order
in which they appear on the pulsed-field gel shown in figure 4, for
ease of comparison.
Figure 2 Inheritance of null alleles in the SMA region. DNA
from family members was analyzed with primers flanking a sublocus
of the multicopy marker C161, termed “CATT-alt.” Analysis was per-
formed on those individuals whose genotypes are shown in figure 1,
as well as on some additional family members. Here, individuals are
shown according to convention: those in lanes 5 and 6 represent in-
dividuals III4 and III5, respectively, both of whom have inherited the
paternal mutant chromosome. The youngest carrier child inherited the
maternal mutant chromosome, but this child died of causes unrelated
to SMA and could not be included in the PFGE analysis shown in
figure 4. Alleles a, b, and c are indicated (right). This figure shows the
inheritance of null alleles, or lack of PCR amplification products, in
carrier and affected individuals. The inheritance of null alleles can be
traced back to the grandparental generation on both sides of the family.
For example, allele a was not inherited by the father of the affected
children (lane 3) from his mother (lane 1). In addition, allele a was
not inherited by the mother (lane 4) from her mother (lane 13). Both
null alleles were therefore passed, on each parental mutant chromo-
some, to the affected children, who are homozygous null for this allele.
alleles of this marker were reported, elsewhere, to be in
linkage disequilibrium with the disease in a Finnish pop-
ulation, suggesting close association of this marker with
the disease gene (Daniels et al. 1995). All three affected
siblings showed homozygous inheritance of null alleles
at this locus. The obligate-carrier status of individual II2
was suggested not only because three of her offspring
were affected by SMA type I but also because her sister,
individual II3, inherited the same mutant chromosome
from their mother and also had a child (individual III6)
affected by SMA. The passage of a null allele at the
CATT-alt locus by her carrier mother is further evidence
of the carrier status of individual II2.
Identification of Maternal Germ-Line Mosaicism
Several members of this SMA type I family were an-
alyzed by PFGE, as part of a larger study, to investigate
further the molecular basis of the SMAmutation. In such
analysis, genomic DNA is subjected to sequential hy-
bridization with probes corresponding to exons 3
(SMN3) and 8 (SMN8) of the SMN gene and to exon
5 of the NAIP gene (NAIP5). (For detailed methodology,
see Campbell et al. 1997.) Figure 3 shows a schematic
representation of the positions of the probes used, in
relation to the position of genes in the SMA region.
Probes SMN3 and SMN8 detect all SMN copies,
whether centromeric or telomeric in origin. In those pa-
tients in whom deletion of SMNtel exons 7 and 8 has
occurred, only SMNcen copies will hybridize to SMN8.
In patients showing no PCR amplification of SMNtel
exons 7 and 8 but in whom gene conversion of SMNtel
to SMNcen has occurred, SMN8 will still hybridize to
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Figure 3 Schematic representation of the SMA region on chromosome 5q13. The inverted duplication containing the SMN, NAIP, and
BTF2p44 genes is shown diagrammatically, with the region depicted by the broken line representing an unknown physical distance. The region
is not drawn to scale. The fully functional SMNtel gene is shown as an unblackened box, the partly functional SMNcen gene as a gray box.
The NAIP genes and the BTF2p44 genes are as labeled. NAIPy represents the centromeric pseudogene copy of NAIP, lacking exon 5. The
approximate positions of the exon-specific probes used in PFGE analysis are shown by arrows. The approximate position of the multicopy
marker C272 (or Ag1CA) is indicated at the 5′ end of each SMN gene copy.
all SMN gene copies. Probe NAIP5 detects only those
DNA fragments originating from the telomeric dupli-
cated region, since the functional telomeric NAIP gene
contains exon 5, whereas the centromeric pseudogene
copy does not (Roy et al. 1995). Thus, DNA fragments
corresponding to SMNtel and SMNcen gene copies can
be distinguished. However, in the case of gene conversion
of SMNtel to SMNcen, the resulting DNA fragment will
hybridize to NAIP5 by virtue of its physical location
within the fragment, even though the fragment no longer
contains the SMNtel gene sequence.
The results of PFGE analysis are presented in figure
4. EagI-digested genomic DNA was hybridized sequen-
tially with SMN3 (fig. 4A), NAIP5 (fig. 4B), and SMN8
(fig. 4C). PFGE analysis yielded an unusual observation
in the mother of this family (individual II2). Although
this individual is an obligate carrier for SMA, panel B
of figure 4 indicates the presence of two DNA fragments
hybridizing to NAIP5, which suggests the presence of
two copies of SMNtel. Approximately 2% of carrier
individuals possess two SMNtel gene copies, both ex-
isting on one chromosome (McAndrew et al. 1997).
However, analysis of the two unaffected children in this
family, individuals III4 and III5, shows that this is not
the case in individual II2. The same single copy of NAIP5
was inherited by both unaffected individuals (fig. 4B,
lanes 6 and 7). The two maternal SMNtel gene copies
must therefore segregate independently. No maternal
SMNcen copy was inherited by child III5, whose DNA
is shown in lane 7. The maternal SMNcen copy (the
smallest hybridizing band in lane 2) is therefore expected
to segregate with the NAIP5 hybridizing fragment not
inherited by these two unaffected offspring. This chro-
mosome does not appear to have been inherited by any
of the offspring in this family. Haplotype analysis re-
vealed that one unaffected child (III4) inherited a mutant
SMA chromosome from her father and a normal chro-
mosome 5 from her mother, whereas the other unaf-
fected child (III5) inherited the normal chromosome from
each parent (see fig. 1). The maternal mutant chromo-
some must therefore be that which appears to carry one
SMNcen gene and one SMNtel gene. This chromosome
would be considered normal with respect to SMA, a
suggestion that conflicts with the obligate-carrier status
of individual II2. The observation of a chromosome that
is expected, on the basis of haplotype analysis, to carry
a mutant SMA allele but that appears to carry an
SMNtel gene in addition to an SMNcen gene may be
explained by gene conversion of the SMNtel copy to
SMNcen. This would result in a mutant chromosome
with no SMNtel copy and two SMNcen copies. A sche-
matic representation of the chromosome complement of
SMN genes in individual II2 is presented in figure 4D.
The PFGE results are also summarized and presented as
SMN and NAIP genotypes in figure 5. The maternal
mutant chromosome representing what is termed here
the “primary mutation” (i.e., gene conversion of SMNtel
to SMNcen) is shown as haplotype C′-D-D in figure 5.
The three affected siblings appear to have inherited
only one SMN gene copy, which does not cohybridize
with NAIP5 and which is therefore is considered to be
centromeric. This is consistent with the severe clinical
course observed in these patients and with the PCR de-
letion analysis that showed lack of amplification of
SMNtel exons 7 and 8, as well as lack of amplification
of NAIP exon 5 (data not shown; Lefebvre et al. 1995;
Roy et al. 1995; van der Steege et al. 1995b). Deter-
mination of the parental origin of the SMNcen copy
inherited by these affected individuals is complicated by
the existence of an SMNcen band of similar size in each
parent (figs. 4A and C, lanes 1 and 2 [the smallest hy-
bridizing band in each case]). As described above, the
maternal SMNcen copy, represented by the lowest SMN-
hybridizing band in lane 2 of figure 4, is expected to
cosegregate with the highest of the two NAIP5-hybrid-
izing fragments in lane 2 of figure 4. This is clearly not
the case in the three affected siblings, and it is assumed,
therefore, that the SMNcen copy in these individuals is
paternal in origin. The possibility exists that the single
SMN-hybridizing EagI fragment in each affected child
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Figure 4 PFGE analysis of a type I family showing maternal
germ-line mosaicism for a second SMA mutation. Lanes 1–7 contain
genomic DNA from family members, digested with EagI. Individuals
II1–III5 are those individuals labeled thus in figure 1. Hybridizations
were carried out by means of probes SMN3 (A), NAIP5 (B), and SMN8
(C). Washes were carried out in 0.5# SSC/0.1% SDS at 65C. Mem-
branes were stripped between hybridizations, and the lack of signal
was determined by autoradiography. PFGE was carried out at 170 V
for 40 h, with pulse-switch time 60 s. Sizes (in kb) relate to yeast
chromosome pulsed field gel (PFG) markers. The carrier status of un-
affected siblings was determined by haplotype analysis (see fig. 1). A
schematic representation of the likely SMN genotype of the mother
(individual II2) is presented in panel D. The upper line represents the
normal maternal chromosome 5 containing one SMNtel gene only.
The lower line represents the mutant maternal chromosome 5 con-
taining two SMNcen copies, one of which (SMNcenC) has arisen by
gene conversion and therefore exists within the telomeric duplicated
region.
contains two SMNcen gene copies, one inherited from
each parent, although this is considered unlikely (see
Discussion).
Discussion
The PFGE analysis of this SMA type I family revealed
an unusual result in the carrier mother of three haplo-
identical affected individuals. Haplotype analysis
showed that the mutant SMA chromosome in the
mother (II2) of these affected children was also inherited
by her sister (II3), who also had a child with SMA, lend-
ing weight to the carrier status of individual II2. It is
likely that the mutant chromosome 5 carried by indi-
vidual II2 contains two SMNcen gene copies, one of
which has arisen by gene conversion from SMNtel. The
gene-conversion event that is assumed to have given rise
to this mutant chromosome did not involve the func-
tional NAIP gene, and it would therefore be expected
that the sister’s affected child (individual III6) would
show amplification and hybridization of NAIP exon 5,
unless a similar second mutation event had occurred in
this side of the family. DNA from this child is unavail-
able, and the child has since died. Although the disease
in this child could have occurred as the result of a new
mutation, this seems highly unlikely in view of (a) the
segregation of SMA in both sides of the family and (b)
the inheritance, by both sisters, of a null CATT-alt allele
from their carrier mother.
Whichever gene complement is present on the mutant
maternal chromosome, none of the affected children
possess hybridizing bands indicative of having inherited
this chromosome. All three possess only one SMNcen
copy, inherited from their father. They do not appear to
have inherited any SMN gene copies from their mother.
The SMN and NAIP genotypes in this family, as deter-
mined by direct analysis of the region by means of gene-
specific probes, are summarized in figure 5. The obser-
vations made in this family can be explained bymaternal
germ-line mosaicism resulting from a second mutational
event in a maternal chromosome already carrying a mu-
tant gene-converted SMA allele, (i.e., two copies of
SMNcen; haplotype C′-D-D in fig. 5). For example, a
chromosome 5 deletion occurring in a germ cell of in-
dividual II2 may have resulted in a population of mutant
germ cells that gave rise to the three affected siblings in
this family. Such a deletion event could result in the loss
of all SMN and NAIP genes on the already mutant chro-
mosome and is represented by maternal haplotype N-
N-N in figure 5. Affected offspring would therefore ap-
pear to inherit no SMN or NAIP gene sequences from
their mother—in other words, null alleles of these
genes—as shown in figure 4.
A second possibility exists, in which a smaller deletion
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Figure 5 Representation of SMN and NAIP genotypes as de-
termined by the pulsed-field genomic analysis shown in fig. 4. Alleles
shown here correlate with the EagI fragments shown in figure 4A, as
follows: A  highest band, lane 1; B  middle band, lane 1; C 
lowest band, lane 1; D  highest band, lane 2; E  middle band, lane
2; and C′  lowest band, lane 2. Alleles C and C′ are so labeled since
they are similar in size and their inheritance cannot be accurately
followed in the affected offspring. Alleles B and E also appear similar
in size in figure 4A but can be distinguished by hybridization with
NAIP5. Null alleles, indicative of gene-deletion events, are represented
by “N.” Normal chromosomes 5 are shown as unblackened bars,
mutant chromosomes as gray-shaded (paternal) or blackened (mater-
nal) bars. The maternal chromosomes 5 carrying the proposed primary
and secondary mutation events are designated “1” and “2,”
respectively.
event has occurred, allowing the original (not gene-con-
verted) SMNcen gene copy to be retained on the ma-
ternal mutant chromosome. In such circumstances, the
three affected siblings would be expected to carry a ma-
ternal SMNcen copy in addition to the SMNcen copy
inherited paternally. The maternal chromosomal contri-
bution, in such a scenario, would be represented by the
haplotype C′-N-N, according to the nomenclature used
in figure 5. As described earlier, one SMNcen copy in
each parent appears almost identical in size (see figures
4A and C, lanes 1 and 2 [the smallest hybridizing band
in each case]). It is possible that a hybridizing band of
this size could contain two SMN gene copies, one in-
herited from each parent. However, there does not ap-
pear to be increased dosage in the lanes in figure 4 that
contain DNA from the affected individuals, compared
with other lanes; the band in lane 5 does appear slightly
more intense, but not enough to account for two gene
copies. The slight discrepancy in size between the same
fragment in all three affected siblings results from dif-
ferences in the amount of DNA in the agarose blocks
loaded in each lane. The observation that DNA in lane
5 has run slightly more slowly equates to the presence
of more DNA in this lane, explaining the slight increase
in band intensity in this individual. A similar difference
in fragment size in the three siblings was observed after
hybridization of the same filter with a probe elsewhere
in the region, which hybridized to fragments different
from those hybridizing to SMN3 and SMN8 (data not
shown). It therefore seems likely that the SMN-hybrid-
izing fragment in each of the three affected siblings har-
bors only one paternally inherited SMNcen gene copy
and that no maternal DNA corresponding to this region
of chromosome 5 has been inherited. The SMN/NAIP
genotypes in the affected offspring (individuals III1, III2,
and III3) are therefore presented as paternal contribution
C-N-N and maternal contribution N-N-N in figure 5.
In an attempt to clarify this issue, analysis of this
family was undertaken with the multicopy marker C272
(Melki et al. 1994). The hope was that, by determination
of the C272 haplotype on each parental mutant chro-
mosome, the genotype of the three affected siblings could
be resolved. Since each SMN gene copy is closely as-
sociated with one C272 allele, it should then have been
possible to determine the number of SMN gene copies
present in the single PFGE fragment observed in each
affected child. However, the same C272 allele was found
to segregate with both the maternal and the paternal
mutant chromosome (data not shown). Thus, only one
C272 allele was observed in each affected child, but it
could not be determined whether these individuals were
homozygous or hemizygous for this allele.
A third, less likely, possibility is somatic mosaicism in
individual II2. In this case, N-N-N may be the original
mutant genotype, and C′-D-D may have arisen by gene
conversion. The paternally inherited genotype N-E-E
might serve as a template for gene conversion of N-N-
N to C′-D-D, a genotype that may or may not represent
an SMA mutation.
The observation of this mutational event in a type I
SMA family highlights the inherent instability of the
SMA region and the high mutation rate in this region.
The use of PFGE enabled us to determine the nature of
the mutation as a secondary event on an already mutant
chromosome, by highlighting the existence of two telo-
meric gene regions in the chromosomes of the mother
of the family, indicating the presence of a gene-converted
allele. The combined use of haplotype analysis and PFGE
allowed us to propose maternal germ-line mosaicism as
the underlying mutational mechanism in this case. It is
interesting to note that the severity of the disease in the
affected individuals of this family was likely to have
increased as a result of the second mutation, in this case
a deletion event. The prevalence of gene conversion in
SMA type I has not yet been determined, since no type
I patients retaining the NAIP gene were available for
analysis by PFGE in the original study (Campbell et al.
1997).
The data presented here have implications for the
counseling of families. The SMA phenotype may evolve,
within a family, as a result of second mutational events
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such as that described here. Alternatively, where there
is a known new mutation, the risk of further affected
children may be higher than the de novo mutation rate
alone.
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